skip to main content
Precision Medicine & Cancer Research

Dr. Sara Rogers Advances Pharmacogenomics, Dementia Prevention, and National Personalized-Medicine Standards

Dr. Sara Rogers, PharmD, BCPS, is a Clinical Assistant Professor in the Department of Translational Medical Sciences at the Institute of Biosciences and Technology (IBT) at Texas A&M University. She works in IBT’s Center for Genomic and Precision Medicine in Houston and also holds an appointment with the School of Engineering Medicine.

Rogers leads a Precision Medicine and Pharmacogenomics Implementation Program that runs precision medicine and clinical pharmacy services at Texas A&M Health. The program includes development and implementation of a pharmacogenomics (PGx) service to optimize medication selection and improve outcomes.

The work integrates genomic information into routine care through pharmacist-led comprehensive medication management, clinical decision support tools, and implementation science research. Her team has built precision medicine dashboards and registries to support that integration.

A second program is AI-enabled dementia prevention and healthy aging research. A multidisciplinary team is using wearables, continuous glucose monitoring, clinical data, and digital biomarkers to identify people at risk of cognitive decline and dementia, aiming for earlier, personalized prevention.

Rogers also chairs the U.S. Pharmacopeia (USP) Personalized Medicines Committee. In that role she leads national standards and guidance for personalized medicines, pharmacogenomics, digital therapeutics, and emerging health technologies.

Learn More

Faculty profile: Dr. Sara Rogers at IBT

Back to All Stories